Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The aim of this procurement is to:
Allow financial measurement of non-drug interventions with assurances that this is not overstated.
Specifically, the tool should look to measure how effective regular clinical pharmacy reviews are in relation to:
Cost savings: non-drug costs and time saved by other health care professionals i.e., increased productivity of the multi-disciplinary team
Cost avoidance: harm reduction through review of medication to reduce errors, adverse drug reactions and avoided hospital admissions
Following development and testing AGCSU would aim to present findings to a wider audience via medicines optimisation forums. The preferred provider would be expected to work in partnership with AGCSU in delivering this presentation.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| MEDOPTIMISE LIMITED | 08898346 | £33,000 | - |